A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) f Nanoparticle Vaccine with Aluminium in Healthy Third-trimester Pregnant Woman; and Safet